Brain Therapeutics is a Central Nervous System Specialty Company focused on the following Therapeutic areas:

  • Psychiatry
  • Neurology
  • Anaesthesiology/Pain
  • Rare (Orphan) Diseases

Brain Therapeutics specializes in in-licensing and commercializing approved products from Central Nervous System Sector to address the unmet medical needs of patients with Mental, Neurological, Neurodevelopmental and Neurodegenerative Disorders as well as Anaesthesia and Pain.

Our initial focus is on products for Psychiatrists, Neurologists, Paediatric Neurologists, Paediatric Psychiatrists and Anaesthesiologists. Headquartered in Athens, Brain Therapeutics has long expertise of commercialization of CNS products not only in Greece but also in Balkan and Eastern Europe countries (13 countries, 66 million population, 3rd biggest territory in Europe).

Brain Therapeutics’ team is built by successful and respected professionals with strong commercial capabilities, proven track record of commercial success in CNS area, dedicated to bringing therapies to the patients with Mental, Neurological, Neurodevelopmental and Neurodegenerative Disorders.

Brain Therapeutics’ team has more than 100 years’ experience within Brain Disorders and commercial capabilities acquired through years of experience in multinational pharma. In addition, the team has a strong network among CNS key opinion leaders and all these years are dedicated to Brain Disorders.

Brain Therapeutics covers high unmet need in sophisticated CNS area. Due to expertise and knowledge of marketing and commercialization of CNS products in multinational pharmaceutical companies, is the ideal partner offering a flexible approach to partnerships and collaborations.